Trial Profile
Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2011
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Seasonal allergic rhinitis; Tree pollen hypersensitivity
- Focus Therapeutic Use
- 08 Dec 2011 New trial record